Norden Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Norden Group's PFE Position: Q2 2026 in Review
Norden Group reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $67.2K and leaving 57,284 shares worth $1.38M. The position accounts for 0.11% of the portfolio, ranked #163.
Norden Group first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.68M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Norden Group held 57,284 shares of Pfizer worth $1.38M as of Q2 2026.
- Norden Group sold 2,569 Pfizer shares in Q2 2026, an estimated $67.2K.
- Pfizer made up 0.11% of Norden Group's portfolio in Q2 2026, its #163 holding.
- Norden Group first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
- Norden Group's Pfizer position peaked at $1.68M in Q1 2026.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.